Roche drug helped breast cancer patients survive longer
Home page > News

Roche drug helped breast cancer patients survive longer

www.reuters.com   | 27.08.2012.

ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said a late-phase trial showed its T-DM1 drug significantly extended the lives of women with advanced breast cancer.
br />

Roche's Genentech said it will be shortly submitting a marketing application to the European Medicines Agency for trastuzumab emtansine (T-DM1) and has already applied for a license with the U.S. Food and Drug Administration.

T-DM1 is seen as a successor to Herceptin for Roche, the world's largest maker of cancer drugs.


Comments (0) Add Your comment Add news < Previous news Next news >






  Add your news >>>